US Panel Backs COVID-19 Boosters Only for Seniors, High-Risk
WASHINGTON (AP) — An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra doses for those who are 65 or older or run a high risk of severe disease.
Get our free mobile app
The twin votes Friday represented a heavy blow to the Biden administration’s sweeping effort to shore up nearly all Americans’ protection amid the spread of the highly contagious delta variant.
The decision was made by a committee of outside experts who advise the Food and Drug Administration.
LOOK: Answers to 30 common COVID-19 vaccine questions
While much is still unknown about the coronavirus and the future, what is known is that the currently available vaccines have gone through all three trial phases and are safe and effective. It will be necessary for as many Americans as possible to be vaccinated in order to finally return to some level of pre-pandemic normalcy, and hopefully these 30 answers provided here will help readers get vaccinated as soon they are able.
More From News Radio 710 KEEL
